Clinical and Medical Engineering Live
- ISSN: 2997-612X
Christina Rahm
Multiple Sclerosis (MS) refers to a complicated autoimmune disorder that characteristically targets adults in their 20’s or 40’s. As stated by Ghaiad [1]. It is the most prevalent disabling neurological disorder among this age group. It results from an abnormal reaction by immune cells that should protect the system against infection. Sclerosis is revealed to be evident in MRI as a result of this autoimmune attack. People may have different symptomatology and clinical courses of the disease as it is a polymorphic entity. Some symptoms associated with MS, particularly when experienced together, can be severe and affect different facets of life for the affected patients. As Sharrack indicated, these manifestations are determined by the intensity and position of the inflammatory response and the amount of deposit build-up [2]. MS attacks the axons in the central nervous system, simultaneously damaging the white and gray matter. In a later stage of the disease, patients experience cortical atrophy that leads to a loss of the outermost component of the brain, i.e., the cerebral cortex [3]. These include symptoms that are characterized by bodily disabilities such as muscle weakness, spasms, or paralysis, as well as tactile disturbances like tingling or pain.